China SXT Pharmaceuticals, Inc. (SXTC) Net Income by Year
China SXT Pharmaceuticals, Inc. reported a net loss of $6.2M in fiscal year 2026. This represents a decrease of 87.8% from the prior fiscal year. The table below carries 10 fiscal years, from 2017 to 2026, and the quarters China SXT Pharmaceuticals, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
SXTC Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
SXTC Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More China SXT Pharmaceuticals, Inc. financials
Frequently Asked Questions
What was China SXT Pharmaceuticals, Inc.'s net income in fiscal year 2026?
China SXT Pharmaceuticals, Inc. reported a net loss of $6.2M in fiscal year 2026.
How fast is China SXT Pharmaceuticals, Inc.'s net income growing?
China SXT Pharmaceuticals, Inc. (SXTC) net income fell by 87.8% year over year, from -$3.3M to -$6.2M in fiscal year 2026.
How has China SXT Pharmaceuticals, Inc.'s net income changed over the years?
Across the 10 fiscal years this page covers, China SXT Pharmaceuticals, Inc. (SXTC) net income went from $1.2M in fiscal year 2017 to -$6.2M in fiscal year 2026.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what China SXT Pharmaceuticals, Inc. (SXTC) reported on that line in every period on record.